Related Experiment Videos
Cutaneous lupoid leishmaniasis: a case report
Ayten Ferahbaş1, Selçuk Mistik, Serap Utaş
1Erciyes University, Kayseri, Turkey.
Cutis
|February 16, 2006
Summary
Cutaneous leishmaniasis, a sandfly-transmitted disease, presents with various skin lesions. A case of lupoid leishmaniasis showed significant improvement after 20 days of meglumine antimoniate treatment.
Area of Science:
- Dermatology
- Infectious Diseases
- Parasitology
Background:
- Cutaneous leishmaniasis is a parasitic infection transmitted by sandflies, characterized by a spectrum of skin manifestations.
- The disease progresses through distinct clinical stages, including papules, nodules, and ulcerative lesions.
Observation:
- A specific form, lupoid leishmaniasis (LL), presents unique dermatological challenges.
- This case highlights the clinical progression from early-stage lesions to more advanced presentations.
Findings:
- Daily intramuscular injections of meglumine antimoniate were administered for 20 days.
- The patient with lupoid leishmaniasis demonstrated marked improvement in clinical features following treatment.
Implications:
- Meglumine antimoniate is an effective treatment option for lupoid leishmaniasis.
- This case underscores the importance of timely and appropriate therapeutic interventions in managing complex leishmaniasis presentations.